Philip Worth Longest (Worth Longest, P Worth Longest)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Preterm Infants

Stem Cell Transplantation

High Efficiency

Top Venues

Pharmaceutical research

AAPS PharmSciTech

Journal of aerosol medicine and pulmonary drug delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad A M Momin, Dale Farkas, Michael Hindle, Felicia Hall, Robert M DiBlasi, Philip Worth Longest
Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization. Pharmaceutical research 41 (8) (2024)
Mohammad A M Momin, Dale Farkas, Michael Hindle, Felicia Hall, Robert M DiBlasi, Philip Worth Longest
Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization. Pharmaceutical research 41 (8) (2024)
Mohammad A M Momin, Dale Farkas, Michael Hindle, Felicia Hall, Robert M DiBlasi, Philip Worth Longest
Correction: Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization. Pharmaceutical research (2024)
Mohammad A M Momin, Dale Farkas, Michael Hindle, Felicia Hall, Robert M DiBlasi, Philip Worth Longest
Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization. Pharmaceutical research 41 (8) (2024)
Mohammad A M Momin, Dale Farkas, Michael Hindle, Felicia Hall, Robert M DiBlasi, Philip Worth Longest
Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization. Pharmaceutical research (2024)
Mohammad A M Momin, Dale Farkas, Michael Hindle, Felicia Hall, Robert DiBlasi, Philip Worth Longest
Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization. Pharmaceutical research (2024)
Connor Howe, Mohammad A M Momin, Ghali Aladwani, Michael Hindle, Philip Worth Longest
Development of a High-Dose Infant Air-Jet Dry Powder Inhaler (DPI) with Passive Cyclic Loading of the Formulation. Pharmaceutical research (2022)
Benjamin M Spence, Philip Worth Longest, Rabijit Dutta, Mohammad A M Momin, Sarah Strickler, Michael Hindle
In Vitro Evaluation of Nebulized Pharmaceutical Aerosol Delivery to the Lungs Using a New Heated Dryer System (HDS). AAPS PharmSciTech 24 (1) (2022)
Dale Farkas, Morgan L Thomas, Amr Hassan, Serena Bonasera, Michael Hindle, Philip Worth Longest
Near Elimination of In Vitro Predicted Extrathoracic Aerosol Deposition in Children Using a Spray-Dried Antibiotic Formulation and Pediatric Air-Jet DPI. Pharmaceutical research (2022)
Connor Howe, Mohammad A M Momin, Karl Bass, Ghali Aladwani, Serena Bonasera, Michael Hindle, Philip Worth Longest
In Vitro Analysis of Nasal Interface Options for High-Efficiency Aerosol Administration to Preterm Infants. Journal of aerosol medicine and pulmonary drug delivery 35 (4) (2022)
Karl Bass, Mohammad A M Momin, Connor Howe, Ghali Aladwani, Sarah Strickler, Arun V Kolanjiyil, Michael Hindle, Robert M DiBlasi, Philip Worth Longest
Characterizing the Effects of Nasal Prong Interfaces on Aerosol Deposition in a Preterm Infant Nasal Model. AAPS PharmSciTech 23 (5) (2022)
Philip Worth Longest, Amr Hassan, Dale Farkas, Michael Hindle
Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation. Pharmaceutical research 39 (2) (2022)